Risk of Malignancy Index (RMI-2) in the Evaluation of Adenexal Masses
DOI:
https://doi.org/10.37506/ijphrd.v11i8.10898Keywords:
RMI-2,Ovarian malignancy,CA-125,U-Score,MenopausalAbstract
The present prospective study, conducted in the department of Obstetrics and Gynaecology and department
of Biochemistry, Government Medical College and Rajindra Hospital,Patiala . Fifty patients after taking
a detailed history and examination underwent various investigations including CA-125 levels and
ultrasonography. RMI-2 was calculated for each patient preoperatively and later compared with respective
histopathological examination. The present study demonstrated that RMI-2 (at a cut-off value of 200) is a
screening method with high sensitivity and specificity in predicting benign or malignant nature of adenexal
masses. It is a simple, easy and useful method to apply in a tertiary care hospital. Our study reconfirms
accuracy of RMI in diagnosing adenexal masses with high risk of malignancy. Small sample size, more
number of pre-menopausal and more number of benign ovarian masses were some of the limitations of
present study.
Downloads
Published
Issue
Section
License
https://creativecommons.org/licenses/by-nc/2.0/deed.en